Literature DB >> 26138013

[Management of complications after revascularization due to peripheral arterial occlusive disease : Prophylaxis and consistent adequate therapy after timely diagnostics].

R I Rückert1, U Hanack, S Aronés-Gomez, S Yousefi, K Brechtel.   

Abstract

BACKGROUND: Complications are a threat to successful revascularization for treatment of perpheral arterial occlusive disease (PAOD) and must, therefore, be either primarily prevented or effectively treated after having occurred.
OBJECTIVES: The aim of this article is to give a survey of possible complications after revascularization for treatment of PAOD and their management.
MATERIAL AND METHODS: A systematic literature review was performed in PubMed and Medline. The analysis mainly considered recent publications with a higher level of evidence.
RESULTS: Revascularization for treatment of PAOD can basically be performed by an open surgical approach, an endovascular approach or as a combination of both methods (hybrid operation). The spectrum of possible complications varies accordingly. A differentiation can be made between bleeding, ischemic and systemic complications as well as between vascular and non-vascular complications. Optimal management of complications begins with primary prophylaxis and further includes a timely diagnosis and treatment of established complications. The best prophylaxis consists of a high quality of indications and performance of revascularization.
CONCLUSION: Optimal management of complications is essential and of utmost importance for successful revascularization to treat PAOD.

Entities:  

Mesh:

Year:  2015        PMID: 26138013     DOI: 10.1007/s00104-015-0042-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  4 in total

1.  Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the Angio-Seal and ProGlide.

Authors:  Kaffer Kara; Amir A Mahabadi; Hanna Rothe; Patrick Müller; Jan Krüger; Horst Neubauer; Oliver Klein-Wiele; Andreas Mügge; Philipp Kahlert; Raimund Erbel
Journal:  J Endovasc Ther       Date:  2014-12       Impact factor: 3.487

Review 2.  Distal bypasses in patients with diabetes and infrapopliteal disease: technical considerations to achieve success.

Authors:  Rachael O Forsythe; Keith G Jones; Robert J Hinchliffe
Journal:  Int J Low Extrem Wounds       Date:  2014-08-14       Impact factor: 2.057

3.  Metabolic syndrome reduces the survival benefit of the obesity paradox after infrainguinal bypass.

Authors:  Dean J Arnaoutakis; Shalini Selvarajah; Nestoras Mathioudakis; James H Black; Julie A Freischlag; Christopher J Abularrage
Journal:  Ann Vasc Surg       Date:  2013-12-24       Impact factor: 1.466

Review 4.  Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.

Authors:  Alistair J Geraghty; Karen Welch
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.